CIP
Chartwell Investment Partners Portfolio holdings
AUM
$2.91B
1-Year Return
40.48%
This Quarter Return
+10.36%
1 Year Return
+40.48%
3 Year Return
+57.19%
5 Year Return
+149.04%
10 Year Return
+395.35%
AUM
$3.44B
AUM Growth
+$225M
(+7%)
Cap. Flow
-$54.8M
Cap. Flow
% of AUM
-1.6%
Top 10 Holdings %
Top 10 Hldgs %
13.72%
Holding
457
New
29
Increased
62
Reduced
284
Closed
34
Top Buys
| 1 |
Visteon
VC
|
$15.3M |
| 2 |
Qualcomm
QCOM
|
$7.75M |
| 3 |
CVS Health
CVS
|
$6.47M |
| 4 |
IBM
IBM
|
$6.1M |
| 5 |
AbbVie
ABBV
|
$5.82M |
Top Sells
| 1 |
CF Industries
CF
|
$11.7M |
| 2 |
Lockheed Martin
LMT
|
$9.06M |
| 3 |
Cisco
CSCO
|
$6.97M |
| 4 |
Home Depot
HD
|
$6.29M |
| 5 |
Microsoft
MSFT
|
$6.24M |
Sector Composition
| 1 | Technology | 20.23% |
| 2 | Financials | 16.52% |
| 3 | Industrials | 12.39% |
| 4 | Consumer Discretionary | 11.85% |
| 5 | Healthcare | 11.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
376
Maravai LifeSciences
MRVI
$343M
| $994K | 0.03% |
23,715
| – | – |
|
377
Full House Resorts
FLL
$123M
| $978K | 0.03% |
80,790
-23,174
| -22% | -$281K |
|
378
Intellia Therapeutics
NTLA
$1.25B
| $974K | 0.03% |
8,239
-158
| -2% | -$18.7K |
|
379
Atkore
ATKR
$1.94B
| $971K | 0.03% |
+8,734
| New | +$971K |
|
380
Baxter International
BAX
$12.1B
| $943K | 0.03% |
10,988
| – | – |
|
381
Stevanato
STVN
$6.31B
| $927K | 0.03% |
41,275
-816
| -2% | -$18.3K |
|
382
DigitalBridge
DBRG
$2.05B
| $923K | 0.03% |
+27,697
| New | +$923K |
|
383
AtriCure
ATRC
$1.76B
| $919K | 0.03% |
13,215
-407
| -3% | -$28.3K |
|
|
CTLT
384
DELISTED
CATALENT, INC.
CTLT
| $891K | 0.03% |
6,959
| – | – |
|
385
Parker-Hannifin
PH
$95.5B
| $885K | 0.03% |
2,782
+1,287
| +86% | +$409K |
|
386
Albemarle
ALB
$9.33B
| $873K | 0.03% |
3,732
| – | – |
|
387
Bandwidth Inc
BAND
$468M
| $868K | 0.03% |
12,094
-216
| -2% | -$15.5K |
|
388
Teradyne
TER
$19.1B
| $800K | 0.02% |
4,892
| – | – |
|
389
Quanta Services
PWR
$56B
| $790K | 0.02% |
6,895
| – | – |
|
390
RingCentral
RNG
$2.76B
| $768K | 0.02% |
4,103
| – | – |
|
391
Darling Ingredients
DAR
$4.93B
| $739K | 0.02% |
10,671
| – | – |
|
392
Century Casinos
CNTY
$83.8M
| $717K | 0.02% |
58,846
-1,203
| -2% | -$14.7K |
|
393
Domo
DOMO
$587M
| $696K | 0.02% |
14,035
-12,399
| -47% | -$615K |
|
394
Fate Therapeutics
FATE
$113M
| $685K | 0.02% |
11,708
-207
| -2% | -$12.1K |
|
395
TETRA Technologies
TTI
$633M
| $676K | 0.02% |
238,178
-4,060
| -2% | -$11.5K |
|
396
DexCom
DXCM
$31.6B
| $649K | 0.02% |
4,832
| – | – |
|
397
iShares 1-3 Year Treasury Bond ETF
SHY
$24.5B
| $622K | 0.02% |
7,270
+2,005
| +38% | +$172K |
|
398
iShares Core S&P 500 ETF
IVV
$665B
| $613K | 0.02% |
1,286
-330
| -20% | -$157K |
|
399
Castle Biosciences
CSTL
$661M
| $596K | 0.02% |
13,901
-245
| -2% | -$10.5K |
|
400
Neurocrine Biosciences
NBIX
$13.9B
| $560K | 0.02% |
6,572
| – | – |
|